IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i18p9853-d638791.html
   My bibliography  Save this article

Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain

Author

Listed:
  • Ruth Usó-Talamantes

    (Conselleria de Sanitat i Salut Pública, Generalitat Valenciana, 46010 Valencia, Spain
    School of Medicine and Health Sciences, Valencia Catholic University, 46001 Valencia, Spain)

  • Silvia González-de-Julián

    (Research Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, Spain)

  • Javier Díaz-Carnicero

    (Research Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, Spain)

  • Inmaculada Saurí-Ferrer

    (INCLIVA Research Institute, 46010 Valencia, Spain)

  • José Luis Trillo-Mata

    (Hospital Valencia Clínico–Malvarrosa, 46010 Valencia, Spain)

  • Marc Carrasco-Pérez

    (Boehringer Ingelheim España S.A., 08174 Barcelona, Spain)

  • Jorge Navarro-Pérez

    (INCLIVA Research Institute, 46010 Valencia, Spain
    Hospital Valencia Clínico–Malvarrosa, 46010 Valencia, Spain
    School of Medicine, University of Valencia, 46010 Valencia, Spain)

  • José Luis Górriz

    (INCLIVA Research Institute, 46010 Valencia, Spain
    Hospital Valencia Clínico–Malvarrosa, 46010 Valencia, Spain
    School of Medicine, University of Valencia, 46010 Valencia, Spain)

  • David Vivas-Consuelo

    (Research Unit for Health Economics and Management, Universitat Politècnica de València, 46022 Valencia, Spain)

  • Josep Redón

    (INCLIVA Research Institute, 46010 Valencia, Spain
    Hospital Valencia Clínico–Malvarrosa, 46010 Valencia, Spain
    School of Medicine, University of Valencia, 46010 Valencia, Spain)

Abstract

This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia Clínico–La Malvarrosa Health District in the year 2015. Patients were stratified with the KDIGO classification for CKD. Additionally, patients were assigned to Clinical Risk Groups (CRGs) according to multimorbidity. Direct costs of primary and specialized care, and medication were estimated. The prevalence of T2D in the database population ( n = 28,345) was 10.8% (mean age (SD) = 67.8 years (13.9); 51.5% male). Up to 14.935 patients (52.6%) had data on kidney function. According to the KDIGO classification, 66.2% of the patients were at low risk of CKD, 20.6% at moderately increased risk, 7.9% at high risk, and 5.2% at very high risk. The average healthcare costs associated with these four risk groups were EUR 3437, EUR 4936, EUR 5899 and EUR 7389, respectively. The large number of T2D patients with CKD in the early stages of the disease generated a significant increase in direct healthcare costs. The economic impact could be mitigated by early and comprehensive therapeutic approaches.

Suggested Citation

  • Ruth Usó-Talamantes & Silvia González-de-Julián & Javier Díaz-Carnicero & Inmaculada Saurí-Ferrer & José Luis Trillo-Mata & Marc Carrasco-Pérez & Jorge Navarro-Pérez & José Luis Górriz & David Vivas-C, 2021. "Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain," IJERPH, MDPI, vol. 18(18), pages 1-14, September.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:18:p:9853-:d:638791
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/18/9853/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/18/9853/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Manel Mata-Cases & Marc Casajuana & Josep Franch-Nadal & Aina Casellas & Conxa Castell & Irene Vinagre & Dídac Mauricio & Bonaventura Bolíbar, 2016. "Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1001-1010, November.
    2. Vivas-Consuelo, David & Usó-Talamantes, Ruth & Trillo-Mata, José Luis & Caballer-Tarazona, Maria & Barrachina-Martínez, Isabel & Buigues-Pastor, Laia, 2014. "Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups," Health Policy, Elsevier, vol. 116(2), pages 188-195.
    3. Julia Thornton Snider & Jeffrey Sullivan & Emma van Eijndhoven & Michael K Hansen & Nobel Bellosillo & Cheryl Neslusan & Ellen O’Brien & Ralph Riley & Seth Seabury & Bertram L Kasiske, 2019. "Lifetime benefits of early detection and treatment of diabetic kidney disease," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-13, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Caballer-Tarazona, Vicent & Guadalajara-Olmeda, Natividad & Vivas-Consuelo, David, 2019. "Predicting healthcare expenditure by multimorbidity groups," Health Policy, Elsevier, vol. 123(4), pages 427-434.
    2. François-Olivier Baudot & Anne-Sophie Aguadé & Thomas Barnay & Christelle Gastaldi-Ménager & Anne Fagot-Campagna, 2019. "Impact of type 2 diabetes on health expenditure: estimation based on individual administrative data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(5), pages 657-668, July.
    3. Joan Gil & Paolo Li Donni & Eugenio Zucchelli, 2019. "Uncontrolled diabetes and health care utilisation: A bivariate latent Markov model approach," Health Economics, John Wiley & Sons, Ltd., vol. 28(11), pages 1262-1276, November.
    4. Alireza Tavakolian & Alireza Rezaee & Farshid Hajati & Shahadat Uddin, 2023. "Hospital Readmission and Length-of-Stay Prediction Using an Optimized Hybrid Deep Model," Future Internet, MDPI, vol. 15(9), pages 1-21, September.
    5. Osuagwu Uchechukwu Levi & Frederick Webb & David Simmons, 2020. "Diabetes Detection and Communication among Patients Admitted through the Emergency Department of a Public Hospital," IJERPH, MDPI, vol. 17(3), pages 1-13, February.
    6. Joan Gil & Antoni Sicras-Mainar & Eugenio Zucchelli, 2018. "Uncontrolled diabetes and health care utilisation: panel data evidence from Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(6), pages 785-795, July.
    7. Maria Consuelo Company-Sancho & Víctor M. González-Chordá & María Isabel Orts-Cortés, 2022. "Variability in Healthcare Expenditure According to the Stratification of Adjusted Morbidity Groups in the Canary Islands (Spain)," IJERPH, MDPI, vol. 19(7), pages 1-13, April.
    8. Ugolini, Cristina & Lippi Bruni, Matteo & Leucci, Anna Caterina & Fiorentini, Gianluca & Berti, Elena & Nobilio, Lucia & Moro, Maria Luisa, 2019. "Disease management in diabetes care: When involving GPs improves patient compliance and health outcomes," Health Policy, Elsevier, vol. 123(10), pages 955-962.
    9. Jou-Yin Chen & Shiqi Deng & Yukiko Wagatsuma, 2023. "Combination of Risks of BMI and Health-Related Lifestyles on Kidney Function in the Prediabetic Japanese Population: A Prospective Cohort Study," IJERPH, MDPI, vol. 20(7), pages 1-10, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:18:p:9853-:d:638791. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.